Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 182
- 试验地点
- 1
- 主要终点
- Number of patients eligible for treatment
研究概览
简要总结
Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic.
This is because the methods and the consequence of following these patients is unknown.
Therefore the investigators will randomize these patients in to two groups:
- One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department.
- The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •R0- resection for primary adenocarcinoma or squamous cell carcinoma of the esophagus, stomach or pancreas.
排除标准
- 未提供
研究组 & 干预措施
Standard outpatient follow-up
Outpatient clinic visits 3,6,9,12,18 and 24 mths after surgery
干预措施: standard follow-up (Behavioral)
Intervention PET/CT and EUS
PET/CT and EUS at 3,6,9,12,18 and 24 months after surgery
干预措施: PET/CT and EUS (Procedure)
结局指标
主要结局
Number of patients eligible for treatment
时间窗: 2 years
Does early detection of recurrent disease translate in to more patients being eligible for oncologic treatment?
次要结局
未报告次要终点
研究者
Michael Bau Mortensen
MD, PhD
Odense University Hospital
